← Back
Data updated: Mar 10, 2026
EMED MEDCL
Pharmaceuticals
EMED MEDCL is a generic drug manufacturer with 1 FDA-approved products.
2007
Since
1
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TERBINAFINE HYDROCHLORIDE 2025-09-12
Labeling
TERBINAFINE HYDROCHLORIDE 2025-09-12
Labeling
TERBINAFINE HYDROCHLORIDE 2025-09-12
Labeling
TERBINAFINE HYDROCHLORIDE 2025-09-11
Labeling
TERBINAFINE HYDROCHLORIDE 2025-09-11
Labeling
TERBINAFINE HYDROCHLORIDE 2024-12-20
Labeling
TERBINAFINE HYDROCHLORIDE 2024-12-20
Labeling
TERBINAFINE HYDROCHLORIDE 2024-12-20
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2007-07-02
- Latest
- 2015-10-28
- Applications
- 1